tiprankstipranks
Trending News
More News >
TME Pharma N.V. (FR:ALTME)
:ALTME
France Market

TME Pharma N.V. (ALTME) Income Statement

Compare
3 Followers

TME Pharma N.V. Income Statement

Last quarter (Q2 2025), TME Pharma N.V.'s total revenue was €27.00K, an increase of Infinity% from the same quarter last year. In Q2, TME Pharma N.V.'s net income was €-2.10M. See TME Pharma N.V.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 19.00K€ 17.00K€ 0.00€ 33.00K€ 35.00
Gross Profit
€ -78.00K€ -127.00K€ -92.00K€ -65.97K€ -62.97K
Operating Expenses
€ 5.20M€ 5.50M€ 12.00M€ 13.45M€ 5.83M
Depreciation and Amortization
€ 17.00K€ 144.00K€ 92.00K€ 66.00K€ 63.00K
EBITDA
€ -5.25M€ -5.07M€ -11.63M€ -12.88M€ -5.29M
Operating Income
€ -5.28M€ -5.62M€ -12.03M€ -13.27M€ -5.77M
Other Income/Expenses
€ -445.00K€ -1.11M€ -3.10M€ -1.19M€ -4.64M
Pretax Income
€ -5.72M€ -6.73M€ -15.13M€ -14.45M€ -10.41M
Net Income
€ -5.72M€ -6.74M€ -15.13M€ -14.45M€ -10.40M
Per Share Metrics
Basic EPS
€ -0.21€ -1.34€ -12.86€ -21.90€ -32.16
Diluted EPS
€ -0.21€ -1.34€ -12.86€ -21.90€ -32.16
Weighted Average Shares Outstanding
27.35M 5.02M 1.18M 659.00K 323.00K
Weighted Average Shares Outstanding (Diluted)
27.35M 5.02M 1.18M 659.85K 323.59K
Currency in EUR

TME Pharma N.V. Earnings and Revenue History